Rifamycin W Analogues from <i>Amycolatopsis mediterranei</i> S699 Δ<i>rif</i>-<i>orf5</i> Strain
Rifamycin W, the most predominant intermediate in the biosynthesis of rifamycin, needs to undergo polyketide backbone rearrangement to produce rifamycin B via an oxidative cleavage of the C-12/C-29 double bond. However, the mechanism of this putative oxidative cleavage has not been characterized yet...
Main Authors: | Yanrong Shi, Feng Ye, Yuliang Song, Xiaochun Zhang, Chunhua Lu, Yuemao Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/7/920 |
Similar Items
-
8-Deoxy-Rifamycin Derivatives from <i>Amycolatopsis mediterranei</i> S699 <i>ΔrifT</i> Strain
by: Feng Ye, et al.
Published: (2020-09-01) -
Scaling up for the industrial production of rifamycin B; optimization of the process conditions in bench-scale fermentor
by: Hewaida F. El-Sedawy, et al.
Published: (2013-06-01) -
Looking Back to <i>Amycolatopsis</i>: History of the Antibiotic Discovery and Future Prospects
by: Olga V. Kisil, et al.
Published: (2021-10-01) -
Rifamycin-Related Polyketides from a Marine-Derived Bacterium <i>Salinispora arenicola</i> and Their Cytotoxic Activity
by: Cao Van Anh, et al.
Published: (2023-09-01) -
Bioprospecting for the soil-derived actinobacteria and bioactive secondary metabolites on the Western Qinghai-Tibet Plateau
by: Lifang Liu, et al.
Published: (2023-10-01)